Nathan Mata

Chief Tech/Sci/R&D Officer at BELITE BIO, INC

Net worth: 3 M $ as of 2026-06-29

60 year

19 connections

Health Technology

Consumer Services

Retail Trade

Profile

Nathan L.
Mata is the founder of ReVision Therapeutics, Inc., founded in 2010, where the title held was Chief Scientific Officer from 2010 to 2012.
Dr. Mata was the founder of Sytera, Inc., founded in 2004, where the title held was Director from 2004 to 2006.
Dr. Mata currently holds the position of Chief Scientific Officer at Belite Bio LLC since 2021.
Dr. Mata currently holds the position of Chief Scientific Officer at Belite Bio, Inc. since 2021.
Former jobs include COO, Director-Research & Development Section at Trethera Corp.
from 2015 to 2017; Chief Scientific Officer, Senior VP-R&D Sector at Sirion Therapeutics, Inc. from 2008 to 2010; and Principal at Jules Stein Eye Institute.
Education includes undergraduate, graduate, and doctorate degrees from The University of Texas at Austin.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BELITE BIO, INC. 0.07%	2026-05-06	16,666 ( 0.07% )	3 M $	2026-06-29

Nathan Mata active positions

Companies	Position	Start
BELITE BIO, INC	Chief Tech/Sci/R&D Officer	2021-10-31
Belite Bio LLC Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company	Chief Tech/Sci/R&D Officer	2021-07-31

All active positions of Nathan Mata

Former positions of Nathan Mata

Companies	Position	End
Trethera Corp. Trethera Corp. Pharmaceuticals: MajorHealth Technology Develops molecule therapies for autoimmune and cancer diseases	Chief Operating Officer	2016-12-31
ReVision Therapeutics, Inc. ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases	Founder	2011-12-31
Sirion Therapeutics, Inc. Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services	Chief Tech/Sci/R&D Officer	2009-12-31
Sytera, Inc. Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products	Founder	2005-12-31
Jules Stein Eye Institute Jules Stein Eye Institute Other Consumer ServicesConsumer Services Operates as eye institute	Corporate Officer/Principal	-

See the detail of Nathan Mata's experience

Training of Nathan Mata

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nathan Mata's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
ReVision Therapeutics, Inc. ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases	Retail Trade
The University of Texas at Austin The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sirion Therapeutics, Inc. Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services	Health Technology
Sytera, Inc. Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products	Health Technology
Jules Stein Eye Institute Jules Stein Eye Institute Other Consumer ServicesConsumer Services Operates as eye institute	Consumer Services
Trethera Corp. Trethera Corp. Pharmaceuticals: MajorHealth Technology Develops molecule therapies for autoimmune and cancer diseases	Health Technology
Belite Bio LLC Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company	Health Technology
Belite Bio, Inc. Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company	Health Technology